Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

NCT04639180

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangxi Medical University Affiliated Tumor Hospital Nanjin, Guangzhou, China
  • Guizhou Cancer Hospital Guiyang, Guizhou, China
  • Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

Ribociclib and Letrozole Treatment in Ovarian Cancer

NCT03673124

Conditions
Adenocarcinoma, Carcinoma, Cystadenocarcinoma, +6 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • UF Heath Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, Not Recruiting

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

NCT02352883

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Kaiser Permanente-San Diego Zion San Diego, California, United States
  • Kaiser Permanente-San Marcos San Marcos, California, United States
  • Greenwich Hospital Greenwich, Connecticut, United States
  • Hartford Hospital Hartford, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)

NCT05030506

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beijing Cancer hospital-Digestive Oncology ( Site 0001) Beijing, Beijing Municipality, China
  • SUN YAT-SEN UNIVERSITY CANCER CENTRE-Urology Surgery Department ( Site 0005) Guangzhou, Guangdong, China
  • Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S Nanjing, Jiangsu, China
  • Tianjin Medical University Cancer Institute and Hospital ( Site 0003) Tianjin, Tianjin Municipality, China
View Trial Details
Active, Not Recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details

Related conditions